In time for World Patient Safety Day, MyMeds&Me has announced the launch of an “enhanced, intuitive, mobile-web version” of its safety reporting solution Reportum Public.

The solution enables patients and healthcare professionals to report adverse events directly to marketing authorisation holders, and will be rolled out to pharmaceutical partners to provide patient and healthcare professionals with access to an integrated solution for direct data capture and digital automation of the overall process.

The platform is designed to work on any device, across multiple regions and languages, while providing high levels of scalability, security and data privacy through its GxP infrastructure, the firm said.

Dr Andrew Rut, chief executive and founder of MyMeds&Me explained that “World Patient Safety Day is an important reminder that patients and indeed consumers are at the centre of everything we do. While WHO estimates that there are 134 million adverse events annually across the globe, the number attributed to adverse drug reactions (ADRs) is likely to be around 15 million. However, given under-reporting this is but a fraction of the true number of ADRs experienced by patients.”

He continued, “With increasing accelerated approvals and an ever greater diversity of the target population, pharmacovigilance systems lack data on the adverse effects of medicines on individuals. Therefore, we are proud to announce the secure mobile-web version of Reportum Public, to further enhance patients’ and healthcare professionals’ user experiences.

“Reportum Public enables data capture around drug safety to go even further, helping the pharmaceuticals industry to map the risk profile of its medicines and ultimately ensure the best outcome for patients.”